The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise ...

Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement.

A new UC study has looked at the evolutionary significance of super genes and their potential role in species survival.

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

A core group of so-called disease detectives, who track outbreaks, was apparently spared. But other young researchers are out ...